|
2022
|
Invention
|
Substituted n-cyanopyrrolidines with activity as usp30 inhibitors.
The present invention relates... |
|
|
Invention
|
Substituted n-cyanopyrrolidines with activity as usp30 inhibitors. The present invention relates ... |
|
|
Invention
|
Compounds. The present invention relates to novel compounds and methods for the manufacture of in... |
|
|
Invention
|
1-cyano-pyrrolidine compounds as usp30 inhibitors.
The present invention relates to novel compou... |
|
|
Invention
|
1-cyano-pyrrolidine derivatives as dub inhibitors. 6 alkyl; A represents an optionally further su... |
|
2021
|
Invention
|
Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (dub) inhibitors.
The presen... |
|
|
Invention
|
N-cyanopyrrolidines with activity as usp30 inhibitors. The present invention relates to a class o... |
|
|
Invention
|
Compounds. 2, X, L and A are as defined herein.
|
|
|
Invention
|
1-(5-(2-cyanopyridin-4-yl)oxazole-2-carbonyl)-4-methylhexahydropyrrolo[3,4-b]pyr role-5(1h)-carbo... |
|
|
Invention
|
N-cyanopyrrolidines with activity as usp30 inhibitors.
The present ... |
|
|
Invention
|
N-(1-cyano-pyrrolidin-3-yl)-5-(3-(trifluoromethyl)phenyl)oxazole-2-carboxamide derivatives and th... |
|
|
Invention
|
N-cyanopyrrolidines with activity as usp30 inhibitors.
The present invention relates to a class ... |
|
2020
|
Invention
|
Substituted cyanopyrrolidines with activity as usp30 inhibitors.
The present invention relates t... |
|
|
Invention
|
Substituted cyanopyrrolidines with activity as usp30 inhibitors. The present invention relates to... |
|
|
Invention
|
Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (dub) inhibitors. The present... |
|
|
Invention
|
Cyanopyrrolidines as dub inhibitors for the treatment of cancer. The present invention relates to... |
|
|
Invention
|
1-cyano-pyrrolidine compounds as usp30 inhibitors. 10, Z, Y and m are as defined herein.
|
|
2019
|
Invention
|
1-cyano-pyrrolidine compounds as usp30 inhibitors. 12, Z, Y and m are as defined herein.
|
|
|
Invention
|
Cyanopyrrolidines as usp30 inhibitors and fibrosis treatment.
The present invention relates to n... |
|
|
Invention
|
Cyanopyrrolidines as usp30 inhibitors and fibrosis treatment. The present invention relates to no... |
|
2018
|
Invention
|
Substituted cyanopyrrolidines with activity as dub inhibitors. The present invention relates to a... |
|
|
Invention
|
Substituted cyanopyrrolidines with activity as dub inhibitors. Substituted Cyanopyrrolidines with... |
|
|
Invention
|
Sulfonamide-substituted cyanopyrrolidines with activity as dub inhibitors. The present invention ... |
|
2017
|
Invention
|
Cyano-substituted heterocycles with activity as inhibitors of usp30. The present invention relate... |
|
|
Invention
|
Cyanopyrrolidine derivatives with activity as inhibitors of usp30. The present invention relates ... |
|
|
Invention
|
Cyano-subtituted heterocycles with activity as inhibitors of usp30. The present invention relates... |
|
|
Invention
|
4,6 dihydropyrrolo [3,4-c] pyrazole-5 (1h)-carbonitrile derivates for treating cancer. 6 cycloalk... |
|
|
Invention
|
2-cyanoisoindoline derivatives for treating cancer. The invention relates to novel compounds of f... |
|
|
Invention
|
Compounds. The present invention relates to novel compounds of formula (I) and methods for the ma... |
|
2016
|
Invention
|
Cyanopyrrolidine derivatives as inhibitors for dubs. 1f and A are as defined herein.
|
|
|
Invention
|
1-cyano-pyrrolidine derivatives as inhibitors of usp30. 3, m, L and X are as defined herein.
|
|
|
Invention
|
Cyanopyrrolidines as dub inhibitors for the treatment of cancer. 9 are as defined herein.
|
|
|
Invention
|
Methods of screening and treatment with usp4 inhibitors. The present application relates to mater... |
|
2011
|
G/S
|
Chemical and proteins for chemical and biological drug discovery, lead identification and diagnos... |
